These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6015447)

  • 1. [Effect of the hydrolysin L-103 transfusion on the functional state of the liver in surgical patients].
    Anishin NS
    Vestn Khir Im I I Grek; 1966 Dec; 97(12):46-8. PubMed ID: 6015447
    [No Abstract]   [Full Text] [Related]  

  • 2. Problems concerning the effect of protein hydrolysate transfusion on the functional state of the liver in surgical patients.
    POLSTYANAYA AV
    Probl Gematol Pereliv Krovi; 1961; 6():630-7. PubMed ID: 14038436
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of heterogenic blood and L-103 hydrolysin on calves].
    Sinkevich VA; Mogilenko AF
    Veterinariia; 1978 Feb; (2):91-3. PubMed ID: 636305
    [No Abstract]   [Full Text] [Related]  

  • 4. [Infusion of L-103 hydrolysin to children with suppurative and inflammatory diseases of the gastro-intestinal tract].
    Smoliak LG; Anishin NS
    Sov Med; 1966 Mar; 29(3):45-9. PubMed ID: 6011763
    [No Abstract]   [Full Text] [Related]  

  • 5. [Liver function and the lipid metabolic status of patients before and after a surgical intervention on the gastrointestinal tract].
    Vasil'kov VG; Kurashvili LV; Kelina NIu; Artem'eva LO
    Anesteziol Reanimatol; 1996; (3):21-5. PubMed ID: 8967611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of protein hydrolysate administration on liver composition.
    Alston WC; Thomson RY
    Cancer Res; 1968 Apr; 28(4):746-52. PubMed ID: 5649063
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the problem of effects of protein hydrolysate transfusion on functional conditions of the liver in surgical patients].
    POLSTIANAIA AV
    Probl Gematol Pereliv Krovi; 1961 Sep; 6():45-51. PubMed ID: 14487693
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aneurysms of the abdominal aorta and associated nonvascular abdominal diseases. Indications and results of combined surgical treatment].
    Stumpo R; Siani A; Marchetti T; Irace L; Gossetti B; Benedetti-Valentini F
    Minerva Cardioangiol; 1998 Sep; 46(9):284-6. PubMed ID: 10021847
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience in using suturing apparatus in emergency operations on the abdominal cavity organs].
    Bondarenko VA; Timofeev VV
    Klin Khir (1962); 1974 Apr; 4():67-9. PubMed ID: 4832337
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of the liver protein hydrolysate on urinary excretion of alanine and glutamic acid in guinea pigs poisoned with lead.
    Bielecka W; Jeske J
    Acta Pol Pharm; 1972; 29(5):524-9. PubMed ID: 4669425
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ureteric and bladder involvement of deep pelvic endometriosis. Value of multidisciplinary surgical management].
    Marcelli F; Collinet P; Vinatier D; Robert Y; Triboulet JP; Biserte J; Villers A
    Prog Urol; 2006 Nov; 16(5):588-93. PubMed ID: 17175957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder dysfunction in patients with cauda equina lesions.
    Podnar S; Trsinar B; Vodusek DB
    Neurourol Urodyn; 2006; 25(1):23-31. PubMed ID: 16224798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ways of widening the utilization of a heterogenic protein preparation, Hydrolysin L-103, in clinical practice].
    Matiashin IM; Skrinskaia GV; Mendel' AK; Baltaĭtis IuV; Balaban VA
    Probl Gematol Pereliv Krovi; 1973 Sep; 18(9):49-50. PubMed ID: 4765498
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with the use of the L-103 hydrolysin in children].
    ANISHIN NS
    Vestn Khir Im I I Grek; 1962 Nov; 89():131-4. PubMed ID: 14013223
    [No Abstract]   [Full Text] [Related]  

  • 15. Does the type of bladder augmentation influence the resolution of pre-existing vesicoureteral reflux? Urodynamic studies.
    Juhasz Z; Somogyi R; Vajda P; Oberritter Z; Fathi K; Pinter AB
    Neurourol Urodyn; 2008; 27(5):412-6. PubMed ID: 17985371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment of vesicoureteral lesions in children].
    Gauens IaK; Dobelis IaZ; Platkais EK
    Khirurgiia (Mosk); 1981 Mar; (3):73-6. PubMed ID: 7265665
    [No Abstract]   [Full Text] [Related]  

  • 17. [CLINICAL USE OF HYDROLYSIN L-103].
    PUSHKAR LN
    Vestn Khir Im I I Grek; 1963 Jul; 91():68-9. PubMed ID: 14070154
    [No Abstract]   [Full Text] [Related]  

  • 18. Protein hydrolysates induce CCK release from enteroendocrine cells and act as partial agonists of the CCK1 receptor.
    Foltz M; Ansems P; Schwarz J; Tasker MC; Lourbakos A; Gerhardt CC
    J Agric Food Chem; 2008 Feb; 56(3):837-43. PubMed ID: 18211011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the problem of the effect of protein hydrolysates on gastric secretion (clinical-experimental study)].
    ANDREEV LV
    Fiziol Zh SSSR Im I M Sechenova; 1961 Jun; 47():764-73. PubMed ID: 13683388
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recommendations on the duration of exemption from mandatory vaccination in gastroenterologic, liver and metabolic diseases].
    Schmutzler S; Ocklitz HW; Scholz H
    Kinderarztl Prax; 1986 Nov; 54(11):641-3. PubMed ID: 3820949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.